📰 Study Start News
Page 3 - Study Start News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Start. Real-time updates on events, politics, business and more.
July 8, 2021
DGAP-News: Heidelberg Pharma berichtet über das erste Halbjahr 2021 vom 08.07.2021, 07:11 Uhr Bild: pixabay.com Heidelberg Pharma berichtet über das erste Halbjahr 2021 08.07.2021 / 07:11 PRESSEMITTEILUNG Heidelberg Pharma berichtet über das erste Halbjahr 2021 - HDP-101: Studienantrag für klinische Studie von der FDA im Februar 2021 genehmigt; Studienzentren bereiten sich auf Aufnahme des ersten Patienten vor, Studienantrag bei Paul-Ehrlich-Institut in Deutschland eingereicht - Neue prä...
June 4, 2021
ADELAIDE, AUS, June 4, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their
May 9, 2021
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand The leading Australian CRO Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. BriefingWire.com, 5/09/2021 - ADELAIDE, AUS, May 7, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadershi...
May 6, 2021
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand ADELAIDE, AUS, May 7, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. Avance Clinical is accredited as a gene technology CRO under the Office of the Gene Techno...
April 22, 2021
ADELAIDE, AU, Apr 22, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. Title: Decentralized Trials - No Going Back Link: https://www.oracle.com/in/industries/life-sciences/health-sciences-connect/sessions/ Time: 23 April, 2021 - 3.05 pm (Australia/Adelaide ACST). Avance Cl...
March 12, 2021
(2) ADELAIDE, AU, Mar 12, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need...
February 26, 2021
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones ADELAIDE, AU, Feb 26, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. The two organizations have been working together to deliver world-class clinical research services...
February 26, 2021
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Mil... The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. BriefingWire.com, 2/26/2021 - The two organizations have been working together to deliver world-cla...